Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $888.6M | $1B | $1.1B | $266.7M | $275.8M | |
| Gross Profit | $468.9M | $553.9M | $596.8M | $146.3M | $154.3M | |
| Operating Income | $195.7M | $259.8M | $276.4M | $75.1M | $75.8M | |
| EBITDA | $201.5M | $265.9M | $282.8M | $76.8M | $77.5M | |
| Diluted EPS | $2.65 | $3.52 | $3.52 | $1.03 | $0.96 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $380M | $359.1M | $383.6M | $442.1M | $514.7M | |
| Total Assets | $514.3M | $514.7M | $573M | $698.1M | $768.8M | |
| Current Liabilities | $232.9M | $284M | $332.8M | $362.2M | $400.4M | |
| Total Liabilities | $275.7M | $316.6M | $362.9M | $420.2M | $459.6M | |
| Total Equity | $238.6M | $198.1M | $210.1M | $278M | $309.2M | |
| Total Debt | $23.9M | $17.2M | $16.2M | $50M | $47.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $213.1M | $278.7M | $347.1M | $62.3M | $93.1M | |
| Cash From Investing | -$5.2M | -$7.5M | -$13.9M | -$1M | -$5.9M | |
| Cash From Financing | -$221.1M | -$241.5M | -$283.4M | -$51.6M | -$51.5M | |
| Free Cash Flow | $207.9M | $271.1M | $333.2M | $61.3M | $87.2M | |
Manhattan Associates, Inc. engages in the business of developing, selling, deploying, servicing, and maintaining software solutions designed to manage supply chains, inventory, and omnichannel operations for retailers, wholesalers, manufacturers, logistics providers, and other organizations. It operates through the following geographical segments: North and Latin America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Deepak Raghavan in October 1990 and is headquartered in Atlanta, GA.
In the current month, MANH has received 5 Buy ratings 4 Hold ratings, and 0 Sell ratings. The MANH average analyst price target in the past 3 months is $223.09.
According to analysts, the consensus estimate is that Manhattan Associates, Inc. share price will rise to $223.09 per share over the next 12 months.
Analysts are divided on their view about Manhattan Associates, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Manhattan Associates, Inc. is a Sell and believe this share price will drop from its current level to $180.00.
The price target for Manhattan Associates, Inc. over the next 1-year time period is forecast to be $223.09 according to 9 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Manhattan Associates, Inc. is a Buy. 5 of 9 analysts rate the stock a Buy at this time.
You can purchase shares of Manhattan Associates, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Manhattan Associates, Inc. shares.
Manhattan Associates, Inc. was last trading at $175.51 per share. This represents the most recent stock quote for Manhattan Associates, Inc.. Yesterday, Manhattan Associates, Inc. closed at $175.29 per share.
In order to purchase Manhattan Associates, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.